INSM today
$118.07-$2.68 (-2.22%)close Nov 12, 2026Trend
DailyUptrend (starting)
4 hourLeaning Bearish
1 hourLeaning Bullish
15 minBullish
5 minDescending Triangle
Daily trend turns down below $90.39
Key levels
Resistance$137.70
Resistance$127.40
Support$116.37
Support$110.58
Latest news & SEC filings
AnalystH.C. Wainwright starts Insmed coverage with Buy rating
AnalystHC Wainwright starts Insmed coverage with Buy rating and $220 price target
All INSM news →About Insmed
Insmed is a biopharmaceutical company focused on therapies for serious lung and inflammatory conditions. It markets ARIKAYCE, an inhaled medicine for a rare mycobacterial lung infection, and BRINSUPRI, an oral drug for a chronic airway disease marked by damaged, widened bronchi. Its pipeline covers pulmonary hypertension, a skin inflammatory condition, and rare neuromuscular disorders. It sells products across North America, Europe, and Asia.
Based on the company's 10-K filed Feb 19, 2026.
Nasdaq · Healthcare
INSMED Inc (INSM)
What Is the Price Target for INSM?
SEPT Low Target
$169.00
SEPT Mid Target
$195.00
SEPT High Target
$245.00
Analyst Consensus
$195.00
Is INSM a Buy or Sell Right Now?
Thesis
- •Revenue growing 66.7% YoY with ACCELERATING trend — accelerating momentum.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for INSM.
Start Free Trial →Is INSM Overvalued or Undervalued?
Valuation Verdict
FAIR
Methods Used
P/B, Analyst Consensus
Fair Value
$148.38
17
Moat Score
NONE
3/9
Piotroski Score
4.2
Altman Z-Score
What Is Smart Money Doing with INSM?
Insider Signal
SELLING
0 buys / 9 sells (90d)
Congress Signal
SELLING
0 buys / 1 sells (90d)
Institutional
N/A
Short Squeeze Risk
MEDIUM
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Hudson Paul | director | Buy | 6,139 | - | Oct 19, 2026 |
| Koppikar Utpal | director | Buy | 6,139 | - | Oct 19, 2026 |
| Brennan David R | director | Sale | 25,000 | $3.1M | Sep 9, 2026 |
| Adsett Roger | officer | Buy | 82,280 | $1.1M | Aug 10, 2026 |
| Adsett Roger | officer | Buy | 76,600 | $1.3M | Aug 10, 2026 |
| Adsett Roger | officer | Buy | 80,970 | $2.5M | Aug 10, 2026 |
| Adsett Roger | officer | Sale | 239,850 | $32.0M | Aug 10, 2026 |
| Flammer Martina M.D. | officer | Buy | 18,278 | $346K | Aug 6, 2026 |
| Flammer Martina M.D. | officer | Buy | 8,895 | $230K | Aug 6, 2026 |
| Flammer Martina M.D. | officer | Sale | 8,895 | $1.1M | Aug 6, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →INSM Growth Story
Revenue YoY
66.7%
3yr Revenue CAGR
35.2%
EPS Growth YoY
-15.26%
FCF Growth YoY
-37.1%
Revenue Trend
ACCELERATING
Dark Pool Trades for INSM
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for INSM, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:00:54 | $118.07 | 1,200 | $$142K | BUY |
| 21:00:54 | $118.07 | 1,092 | $$129K | BUY |
| 21:00:54 | $118.07 | 2,100 | $$248K | BUY |
| 21:00:54 | $118.07 | 2,778 | $$328K | BUY |
| 20:58:03 | $117.96 | 1,000 | $$118K | SELL |
5 dark pool trades shown · $$965K preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for INSM
PREVIEWSEPT Investing provides real-time options flow tracking for INSM, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $130 | Nov 20 | 8 | $$140 | 2 | SWEEP |
| CALL | $135 | Jan 15 | 64 | $$450 | 1 | SWEEP |
| CALL | $135 | Jan 15 | 64 | $$450 | 1 | SWEEP |
| CALL | $135 | Jan 15 | 64 | $$1350 | 3 | SWEEP |
| CALL | $135 | Jan 15 | 64 | $$1350 | 3 | SWEEP |
5 options trades shown · 100% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for INSMED Inc (INSM) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (3 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →INSM — frequently asked questions
What is INSM stock price today?
INSMED Inc (INSM) is at $118.07, down 2.22% (-$2.68) at the Nov 12, 2026 close.
Why is INSM stock moving today?
Latest INSM news — Nov 4, 2026: H.C. Wainwright starts Insmed coverage with Buy rating · Nov 4, 2026: HC Wainwright starts Insmed coverage with Buy rating and $220 price target
What is the INSM price target?
The average analyst price target for INSM is $195.00, ranging from $169 to $245, based on 11 analysts. Latest: Guggenheim maintains on Nov 2, 2026.
What do analysts rate INSM?
Analyst ratings for INSM: 2 Buy, 25 Hold, 0 Sell — consensus Hold.
Did INSM beat earnings?
INSM last reported on Oct 29, 2026: EPS -$0.46 vs -$0.38 expected — a miss of 20.2%.
Does INSM pay a dividend?
INSM does not currently pay a dividend.
How much debt does INSM have?
INSMED Inc reported $547M of debt and $397M of cash (Sep 30, 2026).
What are INSM support and resistance levels?
Support: $116.37, $110.58, $102.69. Resistance: $127.40, $137.70, $142.90.
What are insiders doing with INSM?
Insider activity: SELLING, 0 buys and 9 sells in the last 90 days.
What is the latest news on INSM?
Nov 4, 2026: H.C. Wainwright starts Insmed coverage with Buy rating · Nov 4, 2026: HC Wainwright starts Insmed coverage with Buy rating and $220 price target